Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Anti Tubercular Composition, And Combinatorial Implementations Thereof
Abstract: The present disclosure discloses a composition comprising pranlukast or sorafenib. The present disclosure further discloses use of pranlukast or sorafenib for treating Mycobacterium infections. The present disclosure also discloses a method to identify candidate molecules that are capable of binding to ornithine acetyltransferase (ArgJ) enzyme.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
23 February 2018
Publication Number
35/2019
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
iprdel@lakshmisri.com
Parent Application
Applicants
INDIAN INSTITUTE OF SCIENCE
Indian Institute of Science, Bangalore
Karnataka-560012,India.
Inventors
1. SUROLIA, Avadhesha
Molecular Biophysics
Unit, Indian Institute of
Science, Bangalore, India
2. MISHRA, Archita
Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India
3. MAMIDI, Ashalatha Sreshty
Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India
4. RAJMANI, Raju Shiva
Centre For Infectious Disease Research, Indian Institute of Science Bangalore, India
Specification
DESC:ANTI-TUBERCULAR COMPOSITION, AND COMBINATORIAL IMPLEMENTATIONS THEREOF ,CLAIMS:AS ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201841007013-STATEMENT OF UNDERTAKING (FORM 3) [23-02-2018(online)].pdf | 2018-02-23 |
| 2 | 201841007013-PROVISIONAL SPECIFICATION [23-02-2018(online)].pdf | 2018-02-23 |
| 3 | 201841007013-FORM 1 [23-02-2018(online)].pdf | 2018-02-23 |
| 4 | 201841007013-DRAWINGS [23-02-2018(online)].pdf | 2018-02-23 |
| 5 | 201841007013-FORM-26 [22-05-2018(online)].pdf | 2018-05-22 |
| 6 | Correspondence by Agent_Power of Attorney(Form26)_23-05-2018.pdf | 2018-05-23 |
| 7 | 201841007013-Proof of Right (MANDATORY) [09-07-2018(online)].pdf | 2018-07-09 |
| 8 | Correspondence by Agent _Form 1_11-07-2018.pdf | 2018-07-11 |
| 9 | 201841007013-SEQUENCE LISTING (.txt) [22-02-2019(online)].txt | 2019-02-22 |
| 10 | 201841007013-DRAWING [22-02-2019(online)].pdf | 2019-02-22 |
| 11 | 201841007013-CORRESPONDENCE-OTHERS [22-02-2019(online)].pdf | 2019-02-22 |
| 12 | 201841007013-COMPLETE SPECIFICATION [22-02-2019(online)].pdf | 2019-02-22 |
| 13 | 201841007013-Request Letter-Correspondence [27-02-2019(online)].pdf | 2019-02-27 |
| 14 | 201841007013-Form 1 (Submitted on date of filing) [27-02-2019(online)].pdf | 2019-02-27 |
| 15 | 201841007013-CERTIFIED COPIES TRANSMISSION TO IB [27-02-2019(online)].pdf | 2019-02-27 |
| 16 | 201841007013-FORM-9 [26-07-2019(online)].pdf | 2019-07-26 |
| 17 | 201841007013-FORM 18A [26-07-2019(online)].pdf | 2019-07-26 |
| 18 | 201841007013-FORM 3 [14-08-2019(online)].pdf | 2019-08-14 |
| 19 | 201841007013-FER.pdf | 2019-12-05 |
| 20 | 201841007013-Information under section 8(2) [01-06-2020(online)].pdf | 2020-06-01 |
| 21 | 201841007013-FER_SER_REPLY [01-06-2020(online)].pdf | 2020-06-01 |
| 22 | 201841007013-CLAIMS [01-06-2020(online)].pdf | 2020-06-01 |
| 23 | 201841007013-US(14)-HearingNotice-(HearingDate-31-07-2020).pdf | 2020-07-07 |
| 24 | 201841007013-Correspondence to notify the Controller [28-07-2020(online)].pdf | 2020-07-28 |
| 25 | 201841007013-Written submissions and relevant documents [06-08-2020(online)].pdf | 2020-08-06 |
| 26 | 201841007013-Response to office action [10-11-2020(online)].pdf | 2020-11-10 |
Search Strategy
| 1 | searchstrategy_05-12-2019.pdf |